PAR •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization78.4 mln
Float16.27 mln
Earnings Date05/15/2025
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-5.14
Highly reliable
Relative Strength
8
/ 100
Severely lagging
Debt / Equity
5.97
Extremely leveraged
Pre-Tax Margin
-3,409%
Severely loss-making
Dividend Yield
0.00%
No dividend
Business Description
Adocia is a French biotechnology company founded in 2005 and based in Lyon, focused on developing better treatments for diabetes and obesity. The company uses its proprietary delivery technology to improve how therapeutic proteins, particularly insulins, work in the body, with several products in clinical and early-stage development. Adocia has partnered with Tonghua Dongbao Pharmaceutical to bring one of its key insulin products to markets across China, Asia, and the Middle East.
